The Sprott Junior Uranium Miners ETF (URNJ) has been upgraded to a Strong Buy following a 43% correction, now trading near $19. Despite rising uranium prices projected for 2026, URNJ has underperformed both senior uranium miners and uranium itself. The ETF currently offers an attractive 8.76% dividend yield, making the recent selloff a potential buying opportunity to lower cost basis or increase holdings. However, investors should watch for risks such as a possible drop below the April 2025 low of $11.52 if broader market risk-off events occur.
The Sprott Junior Uranium Miners ETF (URNJ) recently experienced a 43% correction, trading near $19, as noted in market discussions. For readers following Basic Materials-sector US stocks on Pluang, here is the market snapshot as of Oct 12, 2026 22:51 WIB: out of 62 priced stocks, 19 rose and 42 fell. Notable movers include Standard Lithium Ltd (SLI) at USD 1.52 with a -3.48% change and a typical hold time of 24 days, Albemarle Corp. (ALB) at USD 97.89 with a -3.34% change and a 51-day hold time, and Sociedad Quimica y Minera S.A. (SQM) at USD 61.89 with a -3.16% change and a 3-day hold time.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
